Antibiotic-induced Dysbiosis as a Putative Actionable Driver of Cancer Immunity in Renal Cell Carcinoma

Eur Urol. 2020 Aug;78(2):207-208. doi: 10.1016/j.eururo.2020.05.006. Epub 2020 May 23.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacteria
  • Carcinoma, Renal Cell* / drug therapy
  • Dysbiosis / drug therapy
  • Gastrointestinal Microbiome*
  • Humans
  • Immunotherapy
  • Kidney Neoplasms* / drug therapy

Substances

  • Anti-Bacterial Agents